These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4071090)

  • 1. Coagulation profile in systemic lupus erythematosus studies in 20 patients.
    Boey ML; Tsakok FH; Feng PH
    Singapore Med J; 1985; 26(4-5):361-4. PubMed ID: 4071090
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.
    Horellou MH; Aurousseau MH; Boffa MC; Conrad J; Wiesel ML; Samama M
    J Med; 1987; 18(3-4):199-217. PubMed ID: 3480933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
    Yin ET; Gaston LW
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 8. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
    Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of lupus-type circulating anticoagulant in syphilis (author's transl)].
    Guillaume JC; Gouault-Heilmann M; Dumont MD; Touraine R
    Ann Dermatol Venereol; 1981; 108(2):139-43. PubMed ID: 7247216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired coagulation inhibitors. 10 cases (author's transl)].
    Alexandre P; André E; Briquel ME; Labrude P; Streiff F
    Nouv Presse Med; 1980 Oct; 9(39):2901-4. PubMed ID: 7443421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired activated protein C-resistance in patients with lupus anticoagulants.
    Ehrenforth S; Radtke KP; Scharrer I
    Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to hemostasis after traction removal of tunneled cuffed central venous catheters.
    Stecker MS; Johnson MS; Ying J; McLennan G; Agarwal DM; Namyslowski J; Ahmad I; Shah H; Butty S; Casciani T
    J Vasc Interv Radiol; 2007 Oct; 18(10):1232-9; quiz 1240. PubMed ID: 17911513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
    Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The lupus anticoagulant].
    Ordi Ros J; Vilardell Tarrés M
    Med Clin (Barc); 1983 Jul; 81(4):178-81. PubMed ID: 6621149
    [No Abstract]   [Full Text] [Related]  

  • 19. The lupus inhibitor: a study of its heterogeneity.
    Coots MC; Miller MA; Glueck HI
    Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.